| Code | 6668C | ||||||||||
| MA number | 16/0004/18-S | ||||||||||
| Product Form: | tbl flm 20x20 mg (blis.OPA/Al/PVC/Al s fóliou) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 05.01.2018 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Rivaroxabán Sandoz 20 mg_02.2024.pdf
|
| PIL: |
PIL_Rivaroxabán Sandoz 15 mg_20 mg_02.2024.pdf
|
| Dokument: |
Príručka pre predpisujúceho lekára_rivaroxabán_V1.pdf
|
| Safety feature | Yes |
| Data update: | 15.02.2024 |
